Conventional Oncology Products
Wembrace Biopharma is a rapidly growing oncology-focused pharmaceutical company in India, committed to advancing patient care through innovation and quality. We develop and market a comprehensive range of oncology products—from generic cancer therapies to advanced formulations designed to support better treatment outcomes.
With a robust manufacturing and marketing infrastructure, Wembrace Biopharma ensures global-standard quality in every product. Our portfolio also includes innovative collaborations that aim to address unmet clinical needs, supporting improved access to cancer care.
| Brand Name | Molecule | Therapy | Dosage Form | Packing | Description | Package Insert |
|---|---|---|---|---|---|---|
| CARBOWEMB 150 MG INJ 450 MG INJ 600 MG INJ |
Carboplatin | Anti-neoplastic | Vial | 1X150 mg1X450 mg1X600 mg |
Carboplatin is an alkylating agent used to treat advanced ovarian cancer. Early clinical studies of carboplatin were performed in 1982. Carboplatin was developed as an analog of Cisplatin with reduced nephrotoxicity and vomiting | Download PDF (150MG, 450 MG) Download PDF (600 MG) |
| DOCE-ACE 120 MG 20 MG / 80 MG |
Docetaxel | Anti-neoplastic | Vial | 1X120 mg1X80 mg1X20 mg |
Docetaxel is a taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. | Download PDF |
| GEMWEM RTU 1 GM/200 MG | Gemcitabine Hydrochloride | Anti-neoplastic | Vial | 1X1 gm1X200 mg |
Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. | Download PDF |
| IFOWEM 1GM INJ / 2GM INJ | IFOSFAMIDE with Mesna (100Mg) injection | Anti-neoplastic | Vial | 1x1 gm1X2 mg |
Ifosfamide is an alkylating and immunosuppressive agent used in chemotherapy for the treatment of cancers, including testicular cancer, ovarian cancer, cervical cancer, osteosarcoma, bladder cancer, small cell lung cancer, and non-Hodgkin’s lymphoma. Mesna is used to prevent bleeding in the bladder (hemorrhagic cystitis) during chemotherapy with ifosfamide | Download PDF |
| WEMPACLI 100 MG/260 MG/30MG | Paclitaxel | Anti-Neoplastic | Vial | 1X100 mg1X260 mg1X30 mg |
Paclitaxel is a taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer. | Download PDF |
| XELODACE 500 MG | Capecitabine | Anti-Neoplastic | Tablet | 1X10's |
Capecitabine is a nucleoside metabolic inhibitor indicated to treat different gastrointestinal cancers, including pancreatic cancer and breast cancer. | Download PDF |
| ASPARAWEM 5000IU | L-Asparaginase | Anti-neoplastic | Vial | 1X5000 IU |
Asparaginase Escherichia coli is an asparaginase enzyme from E. coli used as part of treatment regimens for acute lymphoblastic leukemias. | Download PDF |
| WEBACE 75MG/100 Mg/125 Mg | Palbociclib | Targeted Therapy | Capsule | 1X7x3's |
Webace 75MG contains Palbociclib. Palbociclib is in a class of medications called kinase inhibitors. Palbociclib is indicated for the treatment of hormone receptor (HR) positive, human epidermal growth factor receptor growth 2 (HER2) negative locally advanced or metastatic breast cancer. | Download PDF |
| LTROMB 25MG/ 50MG | Eltrombopag | Platelet-stimulating agent | Tablet | 1X7's |
Ltromb 25Mg contains Eltrombopag, which is a thrombopoietin receptor agonist used to treat thrombocytopenia or aplastic anemia associated with various etiologies. | Download PDF |
| MEGA-ACE 160MG | Megestrol acetate | Anti-neoplastic | Tablet | 1×10's |
Megaace 80Mg/ 160MG Megestrol acetate is a progestin that is administered orally to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy. | |
| WEMTANIB 250MG | Lapatinib | Anti-neoplastic | Tablet | 1×30's |
Wemtanib 250Mg contains Lapatinib, which is an antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER2-positive breast cancer in patients who received prior chemotherapeutic treatments. |
*Disclaimer: The information provided on this page is intended for informational purposes only and should not be construed as medical advice, diagnosis, or treatment recommendation. Users are advised to consult qualified healthcare professionals where applicable.